Recently, several studies have found that PIK3CD also contributes to cancer progression in several types of solid tumors, such as colorectal cancer (CRC), breast cancer, glioblastoma, squamous cell carcinoma and hepatocellular carcinoma (HCC).16, 17, 18, 19, 20, 21. Here, PIK3CD is linked to cancer.